The temporal profile of butyrylcholinesterase (BuChE) and in vitro << pralidoxime >>-reactivated [[ BuChE ]] was studied in a cohort of 25 organophosphate-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of oxime treatment.